35  Total SME IPOs listed in 2025

1636.98 Crs.  Total funds raised in 2025

27  SME IPOs listed with Gain in 2025

8  SME IPOs listed with loss in 2025

35  Total SME IPOs listed in 2025

1636.98 Crs.  Total funds raised in 2025

27  SME IPOs listed with Gain in 2025

8  SME IPOs listed with loss in 2025

35  Total SME IPOs listed in 2025

1636.98 Crs.  Total funds raised in 2025

27  SME IPOs listed with Gain in 2025

8  SME IPOs listed with loss in 2025

35  Total SME IPOs listed in 2025

1636.98 Crs.  Total funds raised in 2025

27  SME IPOs listed with Gain in 2025

8  SME IPOs listed with loss in 2025

Indegene Limited IPO (Indegene IPO) Details

Indegene Limited is an Pharmaceutical based company, located in Bangalore, Indegene Limited IPO size was 1841.76 Cr. and was issued at 452.00 per share. The share of Indegene Limited were listed at 570.65 per share and are currently trading at 568.70 per share.

Type :
Sub Sector : Digital-led Commercialization Services For The Life Sciences Industry
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
2626.33 Cr.

PAT :
322.53 Cr.

Pricing Report

Issue Price :
452.00

Listing Price :
570.65

Current Market Price :
568.70

Issue Price vs CMP :
116.7 (25.82%)

listing Price vs CMP :
1.9499999999999 (0.34%)

Performance Report (CAGR* wise)

CAGR : 34.34
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Indegene

Company Information
Indegene Limited is a “digital-first” commercialization firm dedicated to the global life sciences industry. Its solutions help biopharmaceutical, emerging biotech, and medical device companies develop products, launch them, and drive sales throughout their lifecycle in a more effective, efficient, and modern way. The company combines over two decades of healthcare domain expertise with fit-for-purpose technology. Its portfolio covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company has established relationships with 19 of the 20 largest biopharmaceutical companies in the world by revenue as of the Financial Year 2021, earning more than 70% of its revenue from these 19 clients for the years 2020, 2021, and 2022. As of June 30, 2022, it had 52 active clients, including 21
Show More
Object of Issue
  • Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc
  • Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc
  • General corporate purposes and inorganic growth

Indegene MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
May, 2024
IPO Size :
1841.76 Cr.
Market Cap :
10814.07 Cr.   
IPO Subscription :
70.30 X     
PE Multiple :
33.53
Merchant Banker :
Citigroup Global Markets India Private Limited
IPO Registrar:
Link Intime India Private Limited
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other MainBoard IPOs in Bangalore

Aadhar Housing Finance Limited

  low income housing segment

  Bangalore


Ajax Engineering Limited

  SLCM machinery that are widely used in infra developments

  Bangalore


Archidply Industries Limited

  plywood manufacturing

  Bangalore


Peer Companies Of This Sector

FAQs

Indegene operates in Pharmaceutical and Digital-led Commercialization Services For The Life Sciences Industry. The Issue is listed on MainBoard in May, 2024. Indegene IPO size was 1841.76 Cr. with Issue price of 452.00 .

Merchant Banker(s) of Indegene IPO: Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited

Indegene IPO subscription was 70.30 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Indegene IPO listed at a listing price of 570.65 against the offer price of 452.00.

The current market price of Indegene is 568.70.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency